Global expenditures on health care are approaching seven trillion US dollars a year, or roughly 10 percent of the world’s gross domestic product. More than 70 percent of these expenditures occur in North America and Europe alone. Not surprisingly, opportunities are immense and growing in the health and life sciences industry, for businesses that include: pharmaceutical and device manufacturers, research and development organizations, information technology companies, providers, clinicians, insurers and entrepreneurs of every stripe.

These opportunities are local, national and global. A 100-bed community hospital in Kansas City wants to form a joint venture for an ambulatory surgery center with 11 cardiologists from St. Louis. A children’s hospital in Abu Dhabi wants to partner with a teaching hospital in Paris. A device manufacturer headquartered in Bonn wishes to market its products in Hong Kong. A Russian pharmaceutical company seeks approval from the US Food and Drug Administration for a new anti-coagulant. An e-health company headquartered in Barcelona wants to license its health records software to an IT consultant in Kampala. The list may be long, but the number of law firms that can handle this range of matters is not.

The firm must have a presence, on the ground and around the world. The firm must have a deep bench of lawyers who have spent decades immersed in the health and life sciences sector, helping organizations navigate continuously evolving political, regulatory and economic landscapes. The firm must understand each jurisdiction’s health care delivery system—from manufacturer to distributor to provider to patient to payor to policy maker—and the firm must be able to provide each of these players with the full range of strategic transactional, regulatory and dispute resolution counseling services.

With offices across 80+ countries and four continents, and with more than 100 lawyers, consultants and policy professionals who have spent their entire professional careers exclusively counseling health care life sciences organizations, Dentons is proud to be that firm.

Learn more about our Health Care sector

Recognition

Chambers Germany 2025: Dentons consolidates its ranking position

February 20, 2025

The inaugural edition of the Chambers Germany guide has recognized 14 Dentons lawyers as leaders in their respective fields. Additionally, Dentons’ teams across Germany received practice and sector rankings in nine areas.

Insights

Dentons Bratislava Life Sciences Newsletter (Slovak)

February 2025

Slovak Republic: We are pleased to present you with a new issue of the Life Sciences Newsletter with interesting events and key news from the decision-making practice of the Ministry of Health of the Slovak Republic and legislation.

Strengthening halal assurance in Indonesia: What's new in government regulation No. 42 of 2024?

February 3, 2025

Indonesia: This updated regulation introduces major changes, including lifetime validity for halal certificates and stricter compliance obligations for businesses.

Foreign Medical Workers and Healthcare Workers Under New Regulations: Utilization and Impacts

December 10, 2024

Indonesia: This article examines the regulation's potential to enhance local expertise, improve healthcare standards, and attract foreign investment in hospitals and clinics.

View all insights for Health Care Practice

News and Events

Recent Press Releases

Dentons HPRP Successfully Hosts Annual Dentons HPRP Law & Regulations Outlook 2025: Shaping the Future of Indonesia’s Digital and Healthcare Sectors

February 27, 2025

Discussions highlighted data centers as a necessity, essential for a robust digital economy and affordable, fast access to digital services. Meanwhile, AI-powered innovations are transforming healthcare diagnostics and patient care, improving efficiency and accessibility across the sector.

Chambers Germany 2025: Dentons consolidates its ranking position

February 20, 2025

The inaugural edition of the Chambers Germany guide has recognized 14 Dentons lawyers as leaders in their respective fields. Additionally, Dentons’ teams across Germany received practice and sector rankings in nine areas.

Dentons Lee Bio Team Introduces the Impact of US Policy Changes on the Biopharmaceutical Industry

October 16, 2024

Dentons Lee’s Bio Team, foreign attorney Bernard K. Ham and senior attorney Peter Seung-Hun Lee introduces the Impact of U.S. Policy Changes on the Biopharmaceutical Industry.

View all press releases for Health Care Practice